Liposomal Doxorubicin in Treating Patients With Persistent or Recurrent Cancer of the Cervix

Stopped early · Phase 2

Conditions studied: Cervical Cancer

In brief

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness liposomal doxorubicin in treating patients who have persistent or recurrent cancer of the cervix.

Key facts

Study ID

NCT00030472

Run by

Gynecologic Oncology Group

Starts

2001-12-01

Last updated by the study team

2013-04-11

Who can join

Age: any. Sex: female. Healthy volunteers: not accepted.

Where it is running

• Jonsson Comprehensive Cancer Center, UCLA — Los Angeles, California, United States
• Community Hospital of Los Gatos — Los Gatos, California, United States
• MBCCOP - Hawaii — Honolulu, Hawaii, United States
• Holden Comprehensive Cancer Center at University of Iowa — Iowa City, Iowa, United States
• Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support — Bethesda, Maryland, United States
• Tufts - New England Medical Center — Boston, Massachusetts, United States
• Cooper University Hospital — Camden, New Jersey, United States
• Roswell Park Cancer Institute — Buffalo, New York, United States
• State University of New York Health Sciences Center - Stony Brook — Stony Brook, New York, United States
• Lineberger Comprehensive Cancer Center, UNC — Chapel Hill, North Carolina, United States
• Charles M. Barrett Cancer Center at University Hospital — Cincinnati, Ohio, United States
• Cleveland Clinic Taussig Cancer Center — Cleveland, Ohio, United States
• Abington Memorial Hospital — Abington, Pennsylvania, United States
• University of Texas Medical Branch — Galveston, Texas, United States
• University of Texas M.D. Anderson CCOP Research Base — Houston, Texas, United States
• Fletcher Allen Health Care - Medical Center Campus — Burlington, Vermont, United States
• Norwegian Radium Hospital — Oslo, Norway

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.